Literature DB >> 9155694

Co-localisation of insulin-like growth factor II and the proliferation marker MIB1 in hepatocellular carcinoma cells.

T Sohda1, Y Oka, K Iwata, J Gunn, S Kamimura, H Shijo, M Okumura, K Yun.   

Abstract

AIM: To assess the effect of insulin-like growth factor II (IGF-II) on proliferation of hepatocellular carcinoma (HCC) cells.
METHODS: Expression of IGF-II mRNA and protein was detected in 10 archival HCC specimens using in situ hybridisation and immunohistochemistry, respectively. Expression of the Ki-67 antigen, a proliferation marker, was determined immunohistochemically on the same sections.
RESULTS: Increased expression of IGF-II mRNA and protein was detected in five of the 10 HCCs in cells located at the periphery of tumour nests. The pattern of localisation of IGF-II was almost identical with that of Ki-67 antigen.
CONCLUSIONS: Most of the Ki-67 antigen positive cells co-expressed IGF-II, suggesting that IGF-II may act as an autocrine or paracrine growth factor, and may play an important role in the development of HCC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155694      PMCID: PMC499738          DOI: 10.1136/jcp.50.2.135

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

Review 1.  Autocrine growth factors and cancer.

Authors:  M B Sporn; A B Roberts
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

2.  Autocrine secretion and malignant transformation of cells.

Authors:  M B Sporn; G J Todaro
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

3.  Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.

Authors:  G Nardone; M Romano; A Calabrò; P V Pedone; I de Sio; M Persico; G Budillon; C B Bruni; A Riccio; R Zarrilli
Journal:  Hepatology       Date:  1996-06       Impact factor: 17.425

4.  Primary liver neoplasms: evaluation of proliferative index using MoAb Ki67.

Authors:  W F Grigioni; A D'Errico; F Bacci; M Gaudio; A Mazziotti; G Gozzetti; A M Mancini
Journal:  J Pathol       Date:  1989-05       Impact factor: 7.996

5.  Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma.

Authors:  C N d'Arville; K T Nouri-Aria; P Johnson; R Williams
Journal:  Hepatology       Date:  1991-02       Impact factor: 17.425

6.  Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.

Authors:  K Yun; A E Fidler; M R Eccles; A E Reeve
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

7.  Expression of insulin-like growth factor II (IGF-II) in human hepatocellular carcinomas: an immunohistochemical study.

Authors:  A D'Errico; W F Grigioni; M Fiorentino; P Baccarini; E Lamas; S De Mitri; G Gozzetti; A M Mancini; C Brechot
Journal:  Pathol Int       Date:  1994-02       Impact factor: 2.534

8.  Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.

Authors:  Q Su; Y F Liu; J F Zhang; S X Zhang; D F Li; J J Yang
Journal:  Hepatology       Date:  1994-10       Impact factor: 17.425

9.  Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice.

Authors:  C E Rogler; D Yang; L Rossetti; J Donohoe; E Alt; C J Chang; R Rosenfeld; K Neely; R Hintz
Journal:  J Biol Chem       Date:  1994-05-13       Impact factor: 5.157

10.  Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum.

Authors:  A C Moses; S P Nissley; P A Short; M M Rechler; R M White; A B Knight; O Z Higa
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more
  11 in total

1.  Expression of insulin like growth factor II and its receptor in hepatocellular carcinogenesis.

Authors:  Z R Fan; D H Yang; J Cui; H R Qin; C C Huang
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  [Molecular mechanisms of progression in human hepatocarcinogenesis].

Authors:  K Breuhahn
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 3.  Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.

Authors:  Nalo Hamilton; Diana Marquez-Garban; Vei H Mah; Yahya Elshimali; David Elashoff; Edward B Garon; Jaydutt Vadgama; Richard Pietras
Journal:  Crit Rev Oncog       Date:  2015

Review 4.  IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?

Authors:  W Zumkeller
Journal:  Mol Pathol       Date:  2001-10

5.  Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression.

Authors:  Nicholas A Shackel; Peter H McGuinness; Catherine A Abbott; Mark D Gorrell; Geoffrey W McCaughan
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

Review 6.  Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.

Authors:  Kai Breuhahn; Peter Schirmacher
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

Review 7.  Targeting insulin-like growth factor axis in hepatocellular carcinoma.

Authors:  Jennifer Wu; Andrew X Zhu
Journal:  J Hematol Oncol       Date:  2011-07-05       Impact factor: 17.388

8.  Characterization of insulin-like-growth factor II (IGF II) mRNA positive hepatic altered foci and IGF II expression in hepatocellular carcinoma during diethylnitrosamine-induced hepatocarcinogenesis in rats.

Authors:  Biswajit Mukherjee; Shampa Ghosh; Tanushree Das; Manika Doloi
Journal:  J Carcinog       Date:  2005-08-10

9.  Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1.

Authors:  D C Martin; J L Fowlkes; B Babic; R Khokha
Journal:  J Cell Biol       Date:  1999-08-23       Impact factor: 10.539

10.  Transcriptomic analysis links hepatocellular carcinoma (HCC) in HZE ion irradiated mice to a human HCC subtype with favorable outcomes.

Authors:  Liang-Hao Ding; Yongjia Yu; Elijah F Edmondson; Michael M Weil; Laurentiu M Pop; Maureen McCarthy; Robert L Ullrich; Michael D Story
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.